Joanne Lee Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Consultant

John Brown University

faculty

19 h-index 148 pubs 1,738 cited

Research Areas

Links

ORCID

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Joanne Lee is a consultant specializing in cancer genomics and diagnostics, with a particular focus on lymphoma and leukemia. Her research encompasses lymphoma diagnosis and treatment strategies, including CAR-T cell therapy, as well as acute myeloid leukemia research. Lee leverages single-cell and spatial transcriptomics to investigate the complexities of these diseases. Her work includes spatially-resolved transcriptomic analysis to reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma. Additionally, she contributed to the establishment of the RUNX1 database and has studied the somatic mutational landscape of hereditary hematopoietic malignancies. Lee's research also explores ex vivo platforms for guiding drug combination treatments in relapsed/refractory lymphoma.

Metrics

h-index: 19
Publications: 148
Citations: 1,738

Selected Publications

Assessing the digital health maturity of general practice in Australia: results from a cross-sectional national survey (2025) DOI
Semi-automated quantification of 18 F-FDG PET-CT in pulmonary TB contacts and its association with prospective outcomes (2025) DOI
Urinary Tumor DNA–based Liquid Biopsy in Bladder Cancer Management: A Systematic Review (2025) DOI
Referring wisely: knowing when and how to make subspecialty consultations in hospital medicine (2024) DOI
Dealing with Death/dying in Medicine (2024) DOI
Ductal, intraductal, and cribriform carcinoma of the prostate: Molecular characteristics and clinical management (2024) DOI
Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma (2024) DOI
Identifying core global mental health professional competencies: A multi-sectoral perspective (2024) DOI
Targeting the DNA damage response in hematological malignancies (2024) DOI
PET-CT-guided characterisation of progressive, preclinical tuberculosis infection and its association with low-level circulating Mycobacterium tuberculosis DNA in household contacts in Leicester, UK: a prospective cohort study (2024) DOI
Efficacy and safety of front-line treatment regimens for Waldenstrom macroglobulinaemia: a systematic review and meta-analysis (2023) DOI
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41 (2023) DOI
Stacked binding of a PET ligand to Alzheimer’s tau paired helical filaments (2023) DOI
Supplementary tables from Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma (2023) DOI
Figure 2 from Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma (2023) DOI